Velomedix has completed enrollment of the first patient in Velocity clinical study of its rapid therapeutic hypothermia system for treating acute myocardial infarction (AMIs or heart attacks). Using a peritoneal-based approach, the ...
Tags: Velomedix, Velocity clinical study, rapid therapeutic hypothermia system
Velomedix has obtained regulatory approval from Health Canada for its pilot study of Velomedix rapid therapeutic hypothermia system, designed for use in patients with acute myocardial infarctions (AMIs or heart attacks). The Velomedix ...
Tags: Velomedix, egulatory approval, Health Canada